Regression of established tumors and metastases by potent vascular endothelial growth factor blockade

Vascular endothelial growth factor (VEGF) is a critical promoter of blood vessel growth during embryonic development and tumorigenesis. To date, studies of VEGF antagonists have primarily focused on halting progression in models of minimal residual cancer. Consistent with this focus, recent clinical...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Huang, Jianzhong, Frischer, Jason S., Serur, Anna, Kadenhe, Angela, Yokoi, Akiko, McCrudden, Kimberly W., New, Tamara, O'Toole, Kathleen, Zabski, Stephanie, Rudge, John S., Holash, Jocelyn, Yancopoulos, George D., Yamashiro, Darrell J., Kandel, Jessica J.
Format: Artigo
Jezik:Inglês
Izdano: National Academy of Sciences 2003
Teme:
Biological Sciences
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC164665/
https://ncbi.nlm.nih.gov/pubmed/12805568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1432908100
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items